메뉴 건너뛰기




Volumn 109, Issue 12, 2014, Pages 1942-1952

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; MICRORNA; MICRORNA 106B; MICRORNA 10B; MICRORNA 132; MICRORNA 155; MICRORNA 181A; MICRORNA 181B; MICRORNA 196A; MICRORNA 21; MICRORNA 212; MICRORNA 30C; UNCLASSIFIED DRUG; TUMOR MARKER;

EID: 84927177778     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.331     Document Type: Article
Times cited : (108)

References (52)
  • 1
    • 33645294070 scopus 로고    scopus 로고
    • Oncomirs-microRNAs with a role in cancer
    • Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
    • (2006) Nat Rev Cancer , vol.6 , pp. 259-269
    • Esquela-Kerscher, A.1    Slack, F.J.2
  • 2
    • 73349125465 scopus 로고    scopus 로고
    • MicroRNAs in cancer: Small molecules with a huge impact
    • Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-56.
    • (2009) J Clin Oncol , vol.27 , pp. 5848-5856
    • Iorio, M.V.1    Croce, C.M.2
  • 3
    • 33644768174 scopus 로고    scopus 로고
    • Control of translation and mRNA degradation by miRNAs and siRNAs
    • Valencia-Sanchez MA, Liu J, Hannon GJ et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-24.
    • (2006) Genes Dev , vol.20 , pp. 515-524
    • Valencia-Sanchez, M.A.1    Liu, J.2    Hannon, G.J.3
  • 4
    • 84858126071 scopus 로고    scopus 로고
    • MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review
    • Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-59.
    • (2012) EMBO Mol Med , vol.4 , pp. 143-159
    • Iorio, M.V.1    Croce, C.M.2
  • 5
    • 84902464275 scopus 로고    scopus 로고
    • MicroRNAs and the cancer phenotype: Profi ling, signatures and clinical implications
    • Stahlhut C, Slack FJ. MicroRNAs and the cancer phenotype: profi ling, signatures and clinical implications. Genome Med 2013; 5: 111.
    • (2013) Genome Med , vol.5 , pp. 111
    • Stahlhut, C.1    Slack, F.J.2
  • 6
    • 70349320158 scopus 로고    scopus 로고
    • Causes and consequences of microRNA dysregulation in cancer
    • Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-14.
    • (2009) Nat Rev Genet , vol.10 , pp. 704-714
    • Croce, C.M.1
  • 7
    • 84876578733 scopus 로고    scopus 로고
    • Targetome profi ling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis
    • Hoffman AE, Liu R, Fu A et al. Targetome profi ling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiol Biomarkers Prev 2013; 22: 327-36.
    • (2013) Cancer Epidemiol Biomarkers Prev , vol.22 , pp. 327-336
    • Hoffman, A.E.1    Liu, R.2    Fu, A.3
  • 8
    • 84883094004 scopus 로고    scopus 로고
    • Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
    • Pizzini S, Bisognin A, Mandruzzato S et al. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 2013; 14: 589.
    • (2013) BMC Genomics , vol.14 , pp. 589
    • Pizzini, S.1    Bisognin, A.2    Mandruzzato, S.3
  • 9
    • 84867740278 scopus 로고    scopus 로고
    • MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics
    • Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther 2012; 19: 723-30.
    • (2012) Cancer Gene Ther , vol.19 , pp. 723-730
    • Xia, H.1    Hui, K.M.2
  • 10
    • 84890708492 scopus 로고    scopus 로고
    • MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression
    • Frampton AE, Castellano L, Colombo T et al. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology 2014; 146: 268-77e18.
    • (2014) Gastroenterology , vol.146 , pp. 268-77e18
    • Frampton, A.E.1    Castellano, L.2    Colombo, T.3
  • 11
    • 84885458012 scopus 로고    scopus 로고
    • MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster
    • Mohr AM, Bailey JM, Lewallen ME et al. MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. PLoS One 2013; 8: e73306.
    • (2013) PLoS One , vol.8 , pp. e73306
    • Mohr, A.M.1    Bailey, J.M.2    Lewallen, M.E.3
  • 12
    • 84884967203 scopus 로고    scopus 로고
    • Micro RNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions
    • Ouyang H, Gore J, Deitz S et al. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene 2013; 33: 4664-74.
    • (2013) Oncogene , vol.33 , pp. 4664-4674
    • Ouyang, H.1    Gore, J.2    Deitz, S.3
  • 13
    • 34248200155 scopus 로고    scopus 로고
    • MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
    • Szafranska AE, Davison TS, John J et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-52.
    • (2007) Oncogene , vol.26 , pp. 4442-4452
    • Szafranska, A.E.1    Davison, T.S.2    John, J.3
  • 14
    • 84894415230 scopus 로고    scopus 로고
    • Hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration
    • Xu L, Li Q, Xu D et al. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol 2014; 44: 459-66.
    • (2014) Int J Oncol , vol.44 , pp. 459-466
    • Xu, L.1    Li, Q.2    Xu, D.3
  • 15
    • 73449134501 scopus 로고    scopus 로고
    • Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
    • Greither T, Grochola LF, Udelnow A et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010; 126: 73-80.
    • (2010) Int J Cancer , vol.126 , pp. 73-80
    • Greither, T.1    Grochola, L.F.2    Udelnow, A.3
  • 16
    • 84888352890 scopus 로고    scopus 로고
    • Targeting microRNAs in pancreatic cancer: Microplayers in the big game
    • Khan S, Ansarullah, Kumar D et al. Targeting microRNAs in pancreatic cancer: microplayers in the big game. Cancer Res 2013; 73: 6541-7.
    • (2013) Cancer Res , vol.73 , pp. 6541-6547
    • Khan, S.1    Ansarullah2    Kumar, D.3
  • 17
    • 34247862190 scopus 로고    scopus 로고
    • MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
    • Bloomston M, Frankel WL, Petrocca F et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-8.
    • (2007) JAMA , vol.297 , pp. 1901-1908
    • Bloomston, M.1    Frankel, W.L.2    Petrocca, F.3
  • 18
    • 84884660965 scopus 로고    scopus 로고
    • Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: Meta-analysis, experimental validation and clinical significance
    • Ma MZ, Kong X, Weng MZ et al. Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res 2013; 32: 71.
    • (2013) J Exp Clin Cancer Res , vol.32 , pp. 71
    • Ma, M.Z.1    Kong, X.2    Weng, M.Z.3
  • 19
    • 84892689249 scopus 로고    scopus 로고
    • MicroRNA biomarkers in whole blood for detection of pancreatic cancer
    • Schultz NA, Dehlendorff C, Jensen BV et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA 2014; 311: 392-404.
    • (2014) JAMA , vol.311 , pp. 392-404
    • Schultz, N.A.1    Dehlendorff, C.2    Jensen, B.V.3
  • 20
    • 84884351594 scopus 로고    scopus 로고
    • Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
    • Makawita S, Dimitromanolakis A, Soosaipillai A et al. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer 2013; 13: 404.
    • (2013) BMC Cancer , vol.13 , pp. 404
    • Makawita, S.1    Dimitromanolakis, A.2    Soosaipillai, A.3
  • 21
    • 0021638331 scopus 로고
    • Classification of pancreatitis
    • Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-9.
    • (1984) Gut , vol.25 , pp. 756-759
    • Sarner, M.1    Cotton, P.B.2
  • 22
    • 84877060316 scopus 로고    scopus 로고
    • Targeting miR-21 for the therapy of pancreatic cancer
    • Sicard F, Gayral M, Lulka H et al. Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther 2013; 21: 986-94.
    • (2013) Mol Ther , vol.21 , pp. 986-994
    • Sicard, F.1    Gayral, M.2    Lulka, H.3
  • 23
    • 79953026892 scopus 로고    scopus 로고
    • MiR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
    • Park JK, Henry JC, Jiang J et al. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 2011; 406: 518-23.
    • (2011) Biochem Biophys Res Commun , vol.406 , pp. 518-523
    • Park, J.K.1    Henry, J.C.2    Jiang, J.3
  • 24
    • 84892912591 scopus 로고    scopus 로고
    • Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-beta to promote proliferation
    • Gore AJ, Deitz SL, Palam LR et al. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-beta to promote proliferation. J Clin Invest 2014; 124: 338-52.
    • (2014) J Clin Invest , vol.124 , pp. 338-352
    • Gore, A.J.1    Deitz, S.L.2    Palam, L.R.3
  • 25
    • 84855543629 scopus 로고    scopus 로고
    • EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefi tinib resistance in lung cancers
    • Garofalo M, Romano G, Di Leva G et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefi tinib resistance in lung cancers. Nat Med 2012; 18: 74-82.
    • (2012) Nat Med , vol.18 , pp. 74-82
    • Garofalo, M.1    Romano, G.2    Di Leva, G.3
  • 26
    • 80755163679 scopus 로고    scopus 로고
    • Signaling pathways in pancreatic cancer
    • Preis M, Korc M. Signaling pathways in pancreatic cancer. Crit Rev Eukaryot Gene Expr 2011; 21: 115-29.
    • (2011) Crit Rev Eukaryot Gene Expr , vol.21 , pp. 115-129
    • Preis, M.1    Korc, M.2
  • 27
    • 84861578195 scopus 로고    scopus 로고
    • Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
    • Liu J, Gao J, Du Y et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012; 131: 683-91.
    • (2012) Int J Cancer , vol.131 , pp. 683-691
    • Liu, J.1    Gao, J.2    Du, Y.3
  • 28
    • 84892583351 scopus 로고    scopus 로고
    • Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells
    • Takiuchi D, Eguchi H, Nagano H et al. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology 2013; 13: 517-23.
    • (2013) Pancreatology , vol.13 , pp. 517-523
    • Takiuchi, D.1    Eguchi, H.2    Nagano, H.3
  • 29
    • 80052445088 scopus 로고    scopus 로고
    • MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma
    • Preis M, Gardner TB, Gordon SR et al. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Clin Cancer Res 2011; 17: 5812-21.
    • (2011) Clin Cancer Res , vol.17 , pp. 5812-5821
    • Preis, M.1    Gardner, T.B.2    Gordon, S.R.3
  • 30
    • 54049115957 scopus 로고    scopus 로고
    • Analysis of microRNAs in pancreatic fi ne-needle aspirates can classify benign and malignant tissues
    • Szafranska AE, Doleshal M, Edmunds HS et al. Analysis of microRNAs in pancreatic fi ne-needle aspirates can classify benign and malignant tissues. Clin Chem 2008; 54: 1716-24.
    • (2008) Clin Chem , vol.54 , pp. 1716-1724
    • Szafranska, A.E.1    Doleshal, M.2    Edmunds, H.S.3
  • 31
    • 77951587943 scopus 로고    scopus 로고
    • MicroRNA expression profi ling to identify and validate reference genes for relative quantification in colorectal cancer
    • Chang KH, Mestdagh P, Vandesompele J et al. MicroRNA expression profi ling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010; 10: 173.
    • (2010) BMC Cancer , vol.10 , pp. 173
    • Chang, K.H.1    Mestdagh, P.2    Vandesompele, J.3
  • 32
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
    • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 33
    • 84943987463 scopus 로고
    • Multiple comparisons among means
    • Dunn OJ. Multiple comparisons among means. J Am Stat Assoc 1961; 56: 52-64.
    • (1961) J Am Stat Assoc , vol.56 , pp. 52-64
    • Dunn, O.J.1
  • 35
    • 79955921754 scopus 로고    scopus 로고
    • FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
    • Conroy T, Desseigne F, Ychou M et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-25.
    • (2011) N Engl J Med , vol.364 , pp. 1817-1825
    • Conroy, T.1    Desseigne, F.2    Ychou, M.3
  • 36
    • 84886741654 scopus 로고    scopus 로고
    • Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
    • Von Hoff DD, Ervin T, Arena FP et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691-703.
    • (2013) N Engl J Med , vol.369 , pp. 1691-1703
    • Von Hoff, D.D.1    Ervin, T.2    Arena, F.P.3
  • 38
    • 84865755577 scopus 로고    scopus 로고
    • MiRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts
    • Matthaei H, Wylie D, Lloyd MB et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012; 18: 4713-24.
    • (2012) Clin Cancer Res , vol.18 , pp. 4713-4724
    • Matthaei, H.1    Wylie, D.2    Lloyd, M.B.3
  • 39
    • 84863115480 scopus 로고    scopus 로고
    • MicroRNA alterations of pancreatic intraepithelial neoplasias
    • Yu J, Li A, Hong SM et al. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012; 18: 981-92.
    • (2012) Clin Cancer Res , vol.18 , pp. 981-992
    • Yu, J.1    Li, A.2    Hong, S.M.3
  • 40
    • 84864840525 scopus 로고    scopus 로고
    • Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue
    • Bauer AS, Keller A, Costello E et al. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One 2012; 7: e34151.
    • (2012) PLoS One , vol.7 , pp. e34151
    • Bauer, A.S.1    Keller, A.2    Costello, E.3
  • 41
    • 84863229384 scopus 로고    scopus 로고
    • Serum microRNA expression profi le as a biomarker in the diagnosis and prognosis of pancreatic cancer
    • Liu R, Chen X, Du Y et al. Serum microRNA expression profi le as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012; 58: 610-8.
    • (2012) Clin Chem , vol.58 , pp. 610-618
    • Liu, R.1    Chen, X.2    Du, Y.3
  • 42
    • 70449700281 scopus 로고    scopus 로고
    • MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease
    • Wang J, Chen J, Chang P et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2: 807-13.
    • (2009) Cancer Prev Res (Phila) , vol.2 , pp. 807-813
    • Wang, J.1    Chen, J.2    Chang, P.3
  • 43
    • 84892691965 scopus 로고    scopus 로고
    • Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?
    • Buchsbaum DJ, Croce CM. Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? JAMA 2014; 311: 363-5.
    • (2014) JAMA , vol.311 , pp. 363-365
    • Buchsbaum, D.J.1    Croce, C.M.2
  • 44
    • 33846595479 scopus 로고    scopus 로고
    • ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
    • Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24: 5313-27.
    • (2006) J Clin Oncol , vol.24 , pp. 5313-5327
    • Locker, G.Y.1    Hamilton, S.2    Harris, J.3
  • 45
    • 53349177819 scopus 로고    scopus 로고
    • Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases
    • Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
    • (2008) Cell Res , vol.18 , pp. 997-1006
    • Chen, X.1    Ba, Y.2    Ma, L.3
  • 46
    • 43449102192 scopus 로고    scopus 로고
    • Detection of elevated levels of tumourassociated microRNAs in serum of patients with diff use large B-cell lymphoma
    • Lawrie CH, Gal S, Dunlop HM et al. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diff use large B-cell lymphoma. Br J Haematol 2008; 141: 672-5.
    • (2008) Br J Haematol , vol.141 , pp. 672-675
    • Lawrie, C.H.1    Gal, S.2    Dunlop, H.M.3
  • 47
    • 80052032965 scopus 로고    scopus 로고
    • Biliary stricture and negative cytology: What next?
    • Cote GA, Sherman S. Biliary stricture and negative cytology: what next? Clin Gastroenterol Hepatol 2011; 9: 739-43.
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 739-743
    • Cote, G.A.1    Sherman, S.2
  • 48
    • 84891739183 scopus 로고    scopus 로고
    • A differential microRNA profi le distinguishes cholangiocarcinoma from pancreatic adenocarcinoma
    • Collins AL, Wojcik S, Liu J et al. A differential microRNA profi le distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol 2013; 21: 133-8.
    • (2013) Ann Surg Oncol , vol.21 , pp. 133-138
    • Collins, A.L.1    Wojcik, S.2    Liu, J.3
  • 49
    • 77955755505 scopus 로고    scopus 로고
    • Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered Micro-RNA expression in solid tumors
    • Sempere LF, Preis M, Yezefski T et al. Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered Micro-RNA expression in solid tumors. Clin Cancer Res 2010; 16: 4246-55.
    • (2010) Clin Cancer Res , vol.16 , pp. 4246-4255
    • Sempere, L.F.1    Preis, M.2    Yezefski, T.3
  • 50
    • 84898761999 scopus 로고    scopus 로고
    • Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis
    • Nie S, Lo A, Wu J et al. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res 2014; 13: 1873-84.
    • (2014) J Proteome Res , vol.13 , pp. 1873-1884
    • Nie, S.1    Lo, A.2    Wu, J.3
  • 51
    • 84856695673 scopus 로고    scopus 로고
    • Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease?
    • Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483-95.
    • (2012) Circ Res , vol.110 , pp. 483-495
    • Creemers, E.E.1    Tijsen, A.J.2    Pinto, Y.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.